In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Isolagen (autologous cellular system--ACS--technology for soft and hard tissue regeneration) has netted about $57mm (including the overallotment; 850k of the 1050k overallotment shares were offered by the selling shareholders) with a 7.2mm common-share follow-on public offering priced at $8.50 per share.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?